The use of GH as a pharmacological agent (minireview)

Endocrine Regulations

Volumn 34, Issue 1, 2000, Pages 28-32

  Wit, J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GONADORELIN DERIVATIVE; GROWTH HORMONE; OXANDROLONE; STEROID;

ADOLESCENT; ASTHMA; BONE DYSPLASIA; BRAIN TUMOR; CHILD; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; DOWN SYNDROME; DRUG INDUCED DISEASE; GONADAL DYSGENESIS; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HUMAN; HYPERINSULINEMIA; IDIOPATHIC DISEASE; INTRAUTERINE GROWTH RETARDATION; KIDNEY TRANSPLANTATION; NOONAN SYNDROME; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; PRADER WILLI SYNDROME; RADIATION INJURY; RHEUMATOID ARTHRITIS; SHORT STATURE; TURNER SYNDROME;

ABNORMALITIES; BONE DISEASES; CHROMOSOME ABERRATIONS; FETAL GROWTH RETARDATION; HUMAN GROWTH HORMONE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; TURNER SYNDROME;

EID: 0034063780     PISSN: 00137200     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. ANNEREN G, GUSTAFSSON J, SARA VR, TUVEMO T: Normalized growth velocity in children with Down's syndrome during growth hormone therapy. J Intellect Disabil Res 37,381-387,1993
2. ANTONIAZZI F, BERTOLDO F, MOTTES M, VALLI M, SIRPESI S, ZAMBONI G, VALENTINI R, TATO L: Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis. J Pediatr 129,432-439,1996
3. APPAN S, LAURENT S, CHAPMAN M, HINDMARSH PC, BROOK CGD: Growth and growth hormone therapy in hypochondroplasia. Acta Paediatr Scand 79,796-803,1990
4. BROECK J VAN DEN, MASSA GG, ATTANASIO A, MATRANGA A, CHAUSSAIN JL, PRIZE DA, AARSKOG D, WIT JM AND THE EUROPEAN STUDY GROUP Final height after long-term growth hormone treatment in Turner Syndrome: results of a European multicenter study. J Pediatr 127,729-735,1995
5. CARREL AL, MYERS SE, WHITMAN BY, ALLEN DB. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: a controlled study. J Pediatr 134,215-221,1999
6. CREMERS MJG, VAN DER TWEEL I, BOERSMA B, WIT JM, ZONDERLAND M: Growth curves of Dutch children with Down Syndrome. J Intellect Disabil Res 40,412-420,1996
7. DE ZEGHER F, FRANCOIS I, VAN HELVOIRT M, VAN DEN BERGHE G: Small as fetus and short as child: from endogenous to exogenous growth hormone. J Clin Endocrinol Metab 82,2021-2026,1997
8. HAGENAES L, RITZEN EM, EKLÖF O, NEUMEYER L, OLLARS B, MÜLLER J, HERTEL NT, SIPILA I, KAITILA I, AEGENAES O, MOHNIKE K: Two years' results on growth hormone treatment in prepubertal children with achondroplasia and hypochondroplasia: a dose study. Hormone Res 46[Suppl 2]:A106,1996
9. HOKKEN-KOELEGA ACS, STIJNEN T, DE MUINCK KEIZER-SCHRAMA SM, WIT JM, WOLFF ED, DE JONG MC, DONCKERWOLCKE RA, ABBAD NC, BOT A, BLUM WF: Placebo-controlled, double-blind, cross-over trials of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 338:585-590,1991
10. HOKKEN-KOELEGA ACS, STIJNEN T, DE RIDDER MA, DE MUINCK KEIZER-SCHRAMA SM, WOLFF ED, DE JONG MC, DONCKERWOLCKE RA, GROOTHOFF JW, BLUM WF, DROP SL: Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet 343:1313-1317,1994
11. HOKKEN-KOELEGA ACS, DE RIDDER MAJ, LEMMEN RJ, DEN HARTOG H, DE MUINCK KEIZER-SCHRAMA SMPF, DROP SL: Children born small for gestational age: do they catch up? Pediatr Res 38,267-271,1995
12. KINUGASA A, FUJITA K, INOUE F, KODO N, SAWADA T: A case of osteogenesis imperfecta type IA with an increased frequency of bone fracture after growth hormone therapy. Acta Paediatr Scand 379, [Suppl]:181,1991
13. NIENHUIS HE, RONGEN-WESTERLAKEN C, GEERTZEN HGM, RIJKERS GT, ZEGERS BJM, WIT JM AND THE DUTCH GROWTH HORMONE WORKING GROUP: Long-term effect of human growth hormone therapy on the prevalence of auto-antibodies in Turner's syndrome. Hormone Res 39(suppl.2),49-53,1993
14. ROMANO AA, BLETHEN SL, DANA K, NOTO RA: Growth hormone treatment in Noonan syndrome: the National Cooperative Growth Study experience. J Pediatr 128.18-21,1996
15. RONGEN-WESTERLAKEN C, WIT JM, MASSA G, KARLBERG J, ALBERTSSON-WIKLAND K, NAERAA RW AND THE DUTCH AND SWEDISCH STUDY GROUP FOR GH TREATMENT: Reference values for height, height velocity and weight in Turner Syndrome. Acta Paediatr 86,937-942,1997
16. ROSENFELD RG, ATTIE KM, FRANE J, BRASEL J, BERNSTEIN S, CARRA JF, CHERNAUSEK S, GOTLIN RW, KUNZE TZ, LIPPE BM, MAHONEY CP, MOORE WV, SAENGER P, JOHANSON AJ: GH therapy of Turner syndrome: beneficial effect on adult height. J Pediatr 132,319-324,1998
17. SAGGESE G, CESARETTI G, BARSANTI S, ROSSI A: Combination treatment with growth hormone and gonadotropin-releasing hormone analogues in short normal girls. J Pediatr 126,468-473,1995
18. SEINO X, MORIWAKE T, TANAKA H, IHOVE M, KANZAKI S, TANAKA T, MATSUO N, NIIMI H: Molecular defects in achondroplasia and the effects of growth hormone treatment. Acta Paediatr 88[Suppl 428]:118-120,1999
19. STAMOYANNOU L, KARACHALIOU F, NEOU P, PAPATAXIARCHOU K, PISTEVOS G, BARTSOCAS CS: Growth and growth hormone therapy in children with achondroplasia. Am J Med Genet 72,71-76,1997
20. SULMONT V, BRAUNER R, FONTOURA M, RAPPAPORT R: Response to growth hormone treatment and final height after cranial or craniospinal irradiation. Acta Paediatr Scand 79,542-549,1990
21. TOUATI G, PRIEUR AM, RUIZ JC, NOEL M, CZERNICHOW P: Beneficial effects of one-year growth hormone administration to children with juvenile chronic arthritis on chronic steroid therapy: effects on growth velocity and body composition. J Clin Endocrinol Metab 83,403-409,1998
22. WIT JM, KAMP GA, RIKKEN B: Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatr Res 39,295-302,1996